QualityStocksNewsBreaks Archives - Page 1218 of 1599

TuesdayOct 08, 2019 11:14 am

QualityStocksNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at Second Annual Advances in Immuno-Oncology USA Congress and World Immunotherapy Congress

INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that its Co-Founder and CEO RJ Tesi, M.D., will present at the 2nd Annual Advances in Immuno-Oncology USA Congress taking place on October 8-9 in San Diego. In addition, Dr. Tesi and Director of Neuroscience CJ Barnum, Ph.D., will present at the World Immunotherapy Congress taking place from October 15-17 in Basel, Switzerland. “The immuno-oncology field is rapidly growing, and emerging new therapies are at the center of attention,” Dr. Tesi said in the news release.…

TuesdayOct 08, 2019 10:54 am

QualityStocksNewsBreaks – B2Digital, Inc.’s (BTDG) B2SN Exceeds 3.9 Million Connections in Q2 2019

B2Digital (OTC: BTDG) today announced that its innovative B2 Social Media Network (“B2SN”) exceeded 3.9 million social media connections in fiscal Q2 2019, indicating the largest audience since B2SN was launched, with 64,543 unique users engaged from July 1st through September 30th, 2019. B2SN permits all six B2Digital-owned companies housed under the B2 Fighting Series brand to interconnect, enabling fans and consumers a simple method of interacting with all six companies’ social media platforms. During Q2, the company’s video viewership numbers also surged as a result of MMA fans viewing B2Digital content on social media. In the three-month period, B2Digital’s…

TuesdayOct 08, 2019 10:42 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF) Launches Distribution in Harris Teeter Supermarkets, Adding Over 250 Stores Across Southeast and Mid-Atlantic Regions

Nightfood Holdings Inc. (OTCQB: NGTF), the innovative company addressing America’s $50 billion nighttime snacking problem, today announced that sleep-friendly Nightfood ice cream is available in the Harris Teeter supermarket chain. According to the update, Harris Teeter, with over 250 locations in North Carolina, South Carolina, Virginia, Georgia, Maryland, Delaware, Florida and the District of Columbia, is Nightfood’s largest retail partner to date. Management is implementing an aggressive promotional program in support of the launch, including featuring, on Nightfood pints, the 2019 Product of the Year logo, which has been shown to increase consumer purchase of new products by 38%. “We…

TuesdayOct 08, 2019 10:10 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Provides R&D Program Update

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today provided an update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine consumer products using Lexaria's patented DehydraTECH(TM) technology. According to the update, most of the investigation and work within the first phase of the project underway between Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc (NYSE:MO) and Lexaria's majority owned subsidiary Lexaria Nicotine LLC is either complete or significantly underway, with imminent commencement of one remaining aspect. Results have been positive to date and support successful completion…

TuesdayOct 08, 2019 10:02 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Cancellation of PCCBD Investment

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Monday announced termination of the proposed investment into The Physician's Choice CBD ("PCCBD") of Phoenix, Arizona, as previously disclosed in April 2019. “I am disappointed to report that after many months of meetings, discussions and attempts to manage an increasingly frustrating process, Chemistree has decided that the proposed $1 million investment into what we believed was a compelling and unique company, cannot be made,” Chemistree President Karl Kottmeier said in the news release. “While scientifically excellent, our due diligence identified significant issues with PCCBD management. We ultimately determined that we could not arrive…

TuesdayOct 08, 2019 9:26 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Receives Health Canada Approval for Facility Expansion

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Monday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has gained Health Canada approval for a significant expansion at its Mississauga, Ontario facility. TerrAscend anticipates that the approval will assist in the company’s goal to meet the growing consumer demand for premium cannabis products and brands expected to surge as the next wave of Canadian cannabis legalization. The approval almost triples TerrAscend's licensed space to 51,800 square feet. The new space will be comprised of supplementary cultivation capacity, a commercial kitchen, formulation rooms…

MondayOct 07, 2019 12:31 pm

QualityStocksNewsBreaks – Trxade Group Inc. (TRXD) Empowers Small, Independent Pharmacies

Integrated pharmaceutical services company Trxade Group (OTCQB: TRXD) provides pricing analytics for its clients, including smaller, independent pharmacies. An article discussing the company reads, “Through its platform, as well as the upcoming launch of other innovative products, Trxade Group is working hard to empower small, independent pharmacies. The company announced that, due to high demand, it will continue rolling out innovative products in the future. New product offerings have already been developed to offer increased data-analysis capacity and better inventory/cost management. . . . User analytics is one of the primary tools that independent pharmacies can rely on to increase…

MondayOct 07, 2019 11:57 am

QualityStocksNewsBreaks – Neutra Corp. (NTRR) Subsidiary Nearing Market Release of Hemp-Based Sports Cream Expected to be Hit with Amateur and Pro Athletes

Early-stage research and development company Neutra Corp. (OTCQB: NTRR) today announced that its subsidiary VIVIS Corp. is rapidly approaching the market release of a new transdermal, hemp-based sports cream. According to the update, the company believes the new product will prove popular with amateur athletes and others seeking relief after tough workouts and performances. The announcement is the latest in Neutra’s series of bold initiatives that it undertook earlier this year to grab a share of a market analysts predict will hit $11 billion by 2026. “We’re now seeing the positive payoff of hiring a dedicated sports medicine advisor earlier…

MondayOct 07, 2019 11:12 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Announces Launch of Edibles Products into Nevada Adult-Use Cannabis Market

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the U.S., this morning announced the launch of its best-selling gummies* into the Nevada market. According to the update, the products are manufactured through the company’s partnership with TapRoot Holdings Inc., a vertically integrated cannabis company operating cultivation and manufacturing facilities in Las Vegas, Nevada. Commercialization comes just four months after PLUS and TapRoot’s entry into a definitive agreement. "Operating in Nevada only four months after signing a definitive agreement with TapRoot is a testament to our commitment to execution in building a national footprint," PLUS…

MondayOct 07, 2019 10:36 am

QualityStocksNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Pioneering Use of Non-Viral Vector Delivery for Gene Therapy Validated by Additional Industry Research

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) today announced additional research in the field validating non-viral vector delivery as the next evolution in gene therapy. Per the update, a recently published paper titled, “Encapsulation, Visualization and Expression of Genes with Biomimetically Mineralized Zeolitic Imidazolate Framework-8 (ZIF-8),” by researchers in Australia, Spain and Austria, supports the belief that non-viral delivery could be a safer alternative for patients than viral vectors, also potentially speeding production time while reducing costs. Genprex was not involved in the study that used a different nanotechnology. “One of the biggest differentiators between Genprex and other gene therapy…

Site Search

Company Search

Category: QualityStocksNewsBreaks